Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase NA 1Phase EARLY_PHASE1 1Phase 3 1Phase 1/2 1Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Classical hematology 1

Conditions

Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Hodgkin Disease 1Genetic Diseases, Inborn 1Anemia, Refractory, with Excess of Blasts 1Anemia, Aplastic 1

Interventions

fludarabine 1Transplantation 1Tablets 1Stem Cell Transplantation 1Roflumilast 1Pemetrexed 1Nadolol 1Isoproterenol 1Introns 1FANG vaccine 1Exercise 1Cyclophosphamide 1Counseling 1Cord Blood Stem Cell Transplantation 1Carvedilol 1Bortezomib 1Bisoprolol 168Ga-pentixafor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Leukemia × Transplantation × Clear all
NCT00212407 2018-11-02

New York Blood Center National Cord Blood Program

New York Blood Center

Phase EARLY_PHASE1 Terminated
4,476 enrolled
Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Aplastic, Anemia, Refractory, with Excess of Blasts, Leukemia, Lymphoma, Genetic Diseases, Inborn

Data powered by HemOnc (CC BY 4.0) Colophon âš¡